Skin cancer screening specialist, The Mole Clinic, finds a partner to support its growth with the help of Oaklins
Deal Announcement
The MOLE Clinic is a leading independent provider of skin cancer screening, diagnosis and treatment services to private patients and to the NHS. It screens over 30,000 patients annually using advanced diagnostic techniques from five London clinics, including on Harley Street, Oxford Circus and Moorgate, as well as via its award-winning tele-dermatology offering to GPs nationally.
Sk:n is the largest network of specialist skin care clinics in the UK and is backed by Trispan, a specialist private equity firm. This acquisition further strengthens Sk:n’s skin cancer screening offering and adds to its growing range of skin care services. As part of integrating the business into the Group, they plan to roll out The MOLE Clinic’s offering across the Sk:n clinic network nationally.
Demand for The MOLE Clinic’s services has been growing and the shareholders were looking for a strategic partner to help support their expansion.
I found the advice and hands on support provided by the Oaklins Smith & Williamson team to be invaluable and a significant factor in achieving a successful transaction. Their understanding of the medical and healthcare sector as well as a focus on owner managed businesses proved vital in not just solving problems but anticipating and addressing them before they arose. I cannot recommend their team highly enough.IAN MACK, FOUNDER AND MANAGING DIRECTOR OF THE MOLE CLINIC, UNITED KINGDOM
Oaklins Smith & Williamson advised skin cancer screening specialist The Mole Clinic on its sale to private equity backed Sk:n
Oaklins Smith & Williamson worked with the shareholders of The MOLE Clinic to deliver a successful sale to a strategic partner that is able to expand the clinic network and help support the business through its next phase of growth.
Talk to our industry specialists
Managing Director
View profile
Director
View profile
